Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “vaccine”

821 pharma patents match "vaccine" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 821
Index total 30,257
Page 14 / 35

Quick answer

This filtered view shows 821 pharmaceutical patents matching "vaccine" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

821 results for “vaccine” · 30,257 patents in full index Clear search

  1. US 10086061

    Combination purified inactivated vaccine for flaviviruses

    The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted

  2. US 10071150

    Immunity enhancing therapeutic vaccine for HPV and related diseases

    MYGT Biopharmaceutical LLC · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted

  3. US 10064923

    Therapeutic cancer vaccines derived from a novel dendritic cell line

    DCPRIME B.V. · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted

  4. US 10058602

    Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted

  5. US 10046045

    Vaccine compositions and uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted

  6. US 10034934

    Porcine epidemic diarrhea virus vaccines and methods of use thereof

    Regents of the University of Minnesota · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted

  7. US 10035981

    Kidney-specific tumor vaccine directed against kidney tumor antigen G-250

    The Regents of the University of California · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted

  8. US 10036751

    Method of evaluating glioblastoma multiforme patient applicable to immunotherapy treatment based on dendritic cell tumor vaccines and method of prognosticating survival rate in glioblastoma mulztiforme patient after treatment

    China Medical University Hospital · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted

  9. US 10016497

    MERS-CoV vaccine

    Inovio Pharmaceuticals, Inc. · Granted Jul 10, 2018 · Expires Jul 5, 2038

    granted

  10. US 10010595

    Live recombinant booster vaccine against tuberculosis

    The Regents of the University of California · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted

  11. US 10010600

    Compositions and methods for administration of vaccines against dengue virus

    Takeda Vaccines, Inc. · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted

  12. US 10010599

    Norovirus vaccine formulations

    Takeda Vaccines, Inc. · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted

  13. US 9993545

    Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom

    Inovio Pharmaceuticals, Inc. · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted

  14. US 9987350

    Antigens and vaccines directed against human enteroviruses

    SENTINEXT THERAPEUTICS Sdn Bhd · Granted Jun 5, 2018 · Expires May 31, 2038

    granted

  15. US 9987347

    Vaccines against multiple subtypes of dengue virus

    Inovio Pharmaceuticals, Inc. · Granted Jun 5, 2018 · Expires May 31, 2038

    granted

  16. US 9974844

    Cancer vaccine compositions and methods of using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 22, 2018 · Expires May 17, 2038

    granted

  17. US 9974851

    Human rotavirus vaccine strains and diagnostics

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 22, 2018 · Expires May 17, 2038

    granted

  18. US 9975926

    Methods of making and using vaccines utilizing minicircle DNA expression vectors for production of foot-and-mouth-disease virus proteins and virus-like particles

    The United States of America, as represented by the Secretary of Homeland Security · Granted May 22, 2018 · Expires May 17, 2038

    granted

  19. US 9968669

    Gene optimized hantaan virus M segment DNA vaccine for hemorrhagic fever with renal syndrome

    The United States of America as represented by the Secretary of the Army · Granted May 15, 2018 · Expires May 10, 2038

    granted

  20. US 9963504

    Anti-CXCL13 antibodies and methods of using the same

    VACCINEX, INC. · Granted May 8, 2018 · Expires May 3, 2038

    granted

  21. US 9932372

    Designer peptide-based PCV2 vaccine

    United Biomedical, Inc. · Granted Apr 3, 2018 · Expires Mar 29, 2038

    granted

  22. US 9919040

    Soluble recombinant plasmodium falciparum circumsporozoite protein, use in vaccines, methods of making and uses thereof

    The United States of America as represented by the Secretary of the Army · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted

  23. US 9913885

    Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same

    Inovio Pharmaceuticals, Inc. · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted

  24. US 9895435

    Vaccines for HSV-2

    IMMUNE DESIGN CORP. · Granted Feb 20, 2018 · Expires Feb 15, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.